EXHIBIT 4.2
LIMITED PARTNER WARRANT
REPLIGEN CORPORATION
WARRANT FOR THE PURCHASE OF SHARES OF COMMON STOCK
NAME AND ADDRESS OF
REGISTERED HOLDER: {NAME}
{ADDRESS 1}
{ADDRESS 0}
{XXXX, XXXXX, XXXXXXX}
{ZIP/POSTAL CODE}
NO. RCP{# OF WARRANTS} {# OF SHARES} SHARES
IN CONSIDERATION OF the grant by the initial registered holder hereof (the
"Initial Holder"), as a limited partner of Repligen Clinical Partners, L.P., a
Delaware limited partnership (the "Partnership"), to Repligen Corporation, a
Delaware corporation (the "Company"), of an option to purchase such Initial
Holder's interest in the Partnership pursuant to the Purchase Agreement dated as
of February 2, 1992, as amended on February 14, 1992 and as amended and restated
on February 28, 1992 (and as further amended from time to time, the "Purchase
Agreement") among the Company and each limited partner of the Partnership and
for value received, the Company hereby grants the rights herein specified and
certifies that the Initial Holder or any registered assignee of the Initial
Holder (each of the Initial Holder and any such registered assignee being
hereinafter referred to as the "Holder") is entitled, subject to the conditions
and upon the terms of this Warrant, to purchase from the Company, at any time or
from time to time during the Exercise Period (as defined in Section 1 hereof),
{# OF SHARES} shares of Common Stock (as defined in Section 1 hereof). The
number of shares of Common Stock to be received upon the exercise of this
Warrant and the Exercise Price are subject to adjustment from time to time as
hereinafter set forth. This Warrant is one of the Warrants issued in connection
with the initial sale of limited partnership interests in the Partnership.
1. CERTAIN DEFINITIONS. Terms defined in the preceding paragraph and elsewhere
in this Warrant have the respective meanings provided for therein. The following
additional terms, as used herein, have the following respective meanings:
"Act" means the Securities Act of 1933, as amended.
"Closing Price" means the closing price per share of the Common Stock on the
principal national securities exchange on which the Common Stock is listed or
admitted to trading or, if not listed or traded on any such exchange, on the
Nasdaq National Market, or if not listed or traded on any such exchange or
system, the average of the bid and asked price per share on Nasdaq National
Market or, if such quotations are not available, the fair market value as
reasonably determined by the Board of Directors of the Company or any committee
of such Board.
"Common Stock" means the fully paid and nonassessable shares of common stock
of the Company, par value $.01 per share, together with any other equity
securities that may be issued by the Company in addition thereto or in
substitution therefor, as provided herein.
"Exchange Act" means the Securities Exchange Act of 1934, as amended.
"Exercise Period" means the period beginning on April 1, 1994 and ending on
March 31, 1999.
"Exercise Price" means $22.73, subject to change or adjustment pursuant to
Section 8 hereof.
"Nasdaq" means the National Association of Securities Dealers Automated
Quotation System.
"National Market" means the National Market of Nasdaq.
"Reorganization Event" means (i) any capital reorganization or leveraged
recapitalization of the Company or reclassification of the Common Stock (other
than a subdivision, combination or reclassification of the outstanding Common
Stock for which adjustment is provided in Section 8(a) hereof and other than a
change in the par value of the Common Stock or an increase in the authorized
capital stock of the Company not involving the issuance of any shares thereof),
(ii) any consolidation of the Company with, or merger of the Company with or
into, another person (including any individual, partnership, joint venture,
corporation, trust or group thereof) (other than a consolidation or merger with
a subsidiary of the Company in which the Company is the continuing corporation
for which adjustment is provided in Section 8(a) hereof) or any sale, lease,
transfer or conveyance of all or substantially all of the property and assets of
the Company or (iii) the announcement or commencement by any "person" or "group"
(within the meaning of Section 13(d) and Section 14(d) of the Exchange Act) of a
bona fide tender offer or exchange offer in accordance with the rules and
regulations of the Exchange Act to purchase, or the acquisition of securities in
the Company, such that after such acquisition or proposed purchase, the acquiror
"beneficially owns" or would "beneficially own" (as defined in Rule 13d-3 under
the Exchange Act), securities in the Company representing 30% or more of the
combined voting power of the Company's then outstanding securities having power
to vote in the election of directors.
"Warrant" means one of the Warrants issued by the Company in connection with
the initial sale of limited partnership interests in the Partnership, including
this Warrant and any Warrant or Warrants which may be issued pursuant to Section
5 hereof in substitution or exchange for or upon transfer of this Warrant, any
Warrant which may be issued pursuant to Section 2 hereof upon partial exercise
of this Warrant and any Warrant which may be issued pursuant to Section 6 hereof
upon the loss, theft, destruction or mutilation of this Warrant.
"Warrant Register" means the register maintained at the principal office of
the Company, or at the office of its agent, in which the name of the Holder of
this Warrant shall be registered.
"Warrant Shares" means the shares of Common Stock, as adjusted from time to
time, deliverable upon exercise of this Warrant.
2. EXERCISE OF WARRANT. This Warrant may be exercised, in whole or in part, at
any time or from time to time during the Exercise Period, by presentation and
surrender hereof to the Company at its principal office at the address set forth
on the signature page hereof (or at such other address of the Company or any
agent appointed by the Company to act hereunder as the Company or such agent may
hereafter designate in writing to the Holder), with the purchase form annexed
hereto (the "Purchase Form") duly executed and accompanied by cash or a
certified or official bank check drawn to the order of "REPLIGEN CORPORATION"
(or its successor in interest, if any) in the amount of the Exercise Price,
multiplied by the number of Warrant Shares specified in such Purchase Form. If
this Warrant should be exercised in part only, the Company or its agent shall,
upon surrender of this Warrant, execute and deliver a Warrant evidencing the
right of the Holder thereof to purchase the balance of the Warrant Shares
purchasable hereunder. Upon receipt by the Company during the Exercise Period of
this Warrant and such Purchase Form in proper form for exercise, together with
proper payment of the Exercise Price at its principal office, or by its agent at
its office, the Holder shall be deemed to be the holder of record of the number
of Warrant Shares specified in such Purchase Form; provided, however, that if
the date of such receipt by the Company or its agent is a date on which the
stock transfer books of the Company are closed, such person shall be deemed to
have become the record holder of such shares on the next business day on which
the stock transfer books of the Company are open. The Company shall pay any and
all documentary, stamp or similar issue or transfer taxes payable in respect of
the issue or delivery of such Warrant Shares. Any Warrant issued upon partial
exercise of this Warrant pursuant to this Section 2 shall be dated the date of
this Warrant.
3. RESERVATION OF SHARES. The Company agrees that at all times it will keep
reserved solely for issuance and delivery pursuant to the Warrants the number of
shares of its Common Stock that are or would be issuable from time to time upon
exercise of all Warrants issued in connection with the initial sale of limited
partnership interests in the Partnership. All such shares shall be duly
authorized and, when issued upon such exercise, shall be validly issued, fully
paid and nonassessable, free and clear of all liens, security interests, charges
and other encumbrances or restrictions on sale and free of all preemptive
rights. Before taking any action that would cause an adjustment pursuant to
Section 8 hereof reducing the Exercise Price below the then par value (if any)
of the Warrant Shares issuable upon exercise of this Warrant, the Company will
take any corporate action that may, in the opinion of its counsel, be necessary
in order that the Company may validly and legally issue fully paid and
nonassessable Warrant Shares at the Exercise Price as so adjusted.
4. WARRANT SHARE REGISTRATION RIGHTS.
(a) The Company has (i) prepared and filed with the Securities and
Exchange Commission (the "SEC") under the Act a registration statement with
respect to the Warrant Shares issuable upon exercise of all Existing
Warrants issued in connection with the initial sale of limited partnership
interests in the Partnership and will use its best efforts to cause such
registration statement to remain effective under the Act during the Exercise
Period while any of such Warrants are outstanding and (ii) register or
qualify such Warrant Shares under the securities or Blue Sky laws of each
jurisdiction within the United States in which such registration or
qualification is necessary in connection with the issuance and delivery of
such Warrant Shares to the Holders of the Warrants.
(b) In connection with the registration and qualification referred to in
subsection (a) of this Section 4, the Company covenants and agrees:
(i) as expeditiously as possible, to prepare and file with the SEC
such amendments and supplements to such registration statement and the
prospectus used in connection therewith as may be necessary to keep such
registration statement effective throughout the Exercise Period;
(ii) as expeditiously as possible, to take such action as may be
necessary or desirable to maintain the registration and qualification of
the Warrant Shares under the securities or Blue Sky laws of the
jurisdictions referred to in subsection (a) of this Section 4; and
(iii) to pay all expenses incurred by the Company in complying with
subsection (a) of this Section 4 and this subsection (b), including (A)
all registration and filing fees, (B) all printing expenses, (C) all fees
and disbursements of its counsel and independent public accountants and
(D) all Blue Sky fees and expenses (including fees and disbursements of
counsel).
5. EXCHANGE, TRANSFER OR ASSIGNMENT OF WARRANT.
(a) If the Holder has received an opinion of counsel satisfactory to the
Company that this Warrant may be freely sold or transferred without
registration under the Act, this Warrant may be, at the option of the
Holder, and upon presentation and surrender hereof to the Company or at the
office of its stock transfer agent, (i) exchanged for other Warrants of
different denominations, entitling the Holder or Holders thereof to purchase
in the aggregate the same number of Warrant Shares at the Exercise Price or
(ii) if delivered together with a written notice specifying the
denominations in which new Warrants are to be issued and signed by the
Holder hereof, divided or combined with other Warrants that carry the same
rights.
(b) If the Holder has received an opinion of counsel satisfactory to the
Company that this Warrant may be freely sold or transferred without
registration under the Act, this Warrant may be assigned, at the option of
Holder, upon surrender of this Warrant to the Company or at the
office of its stock transfer agent, with the Warrant Assignment Form annexed
hereto duly executed and accompanied by funds sufficient to pay any transfer
tax. The Company shall execute and deliver a new Warrant or Warrants in the
name of the assignee or assignees named in such instrument of assignment
and, if the Holder's entire Interest is not being transferred or assigned,
in the name of the Holder, and this Warrant shall promptly be canceled.
(c) Any transfer or exchange of this Warrant shall be without charge to
the Holder and any new Warrant or Warrants issued pursuant to this Section 5
shall be dated the date hereof.
6. LOST, MUTILATED OR MISSING WARRANT. Upon receipt by the Company or its agent
of evidence satisfactory to it of the loss, theft or destruction of this
Warrant, and of satisfactory indemnification, and upon surrender and
cancellation of this Warrant if mutilated, the Company or its agent shall
execute and deliver a Warrant of like tenor and date in exchange for this
Warrant.
7. RIGHTS OF THE HOLDER. The Holder shall not, by virtue hereof, be entitled to
any rights of a shareholder in the Company, either at law or in equity, and the
rights of the Holder are limited to those expressed in this Warrant.
8. ANTI-DILUTION. (a) If the Company shall fix or have fixed a record date at
any time after the date hereof and before the expiration of the Exercise Period
for:
(i) STOCK DIVIDENDS, SUBDIVISIONS, COMBINATIONS, RECLASSIFICATIONS,
ETC. (A) The declaration of a dividend or distribution on the Common Stock
(or other securities deliverable hereunder) payable in shares of capital
stock (whether shares of Common Stock or of capital stock of any other
class), (ii) the subdivision of shares of the Common Stock into a greater
number of shares, (iii) the combination of the Common Stock into a smaller
number of shares or (iv) the issuance of any shares of its capital stock by
reclassification of the Common Stock in connection with a consolidation or
merger with a subsidiary of the Company in which the Company is the
continuing corporation, then, in any such event, the Holder shall be
entitled to receive the aggregate number and kind of shares which, if the
Warrant had been exercised immediately prior to such record date, he would
have been entitled to receive by virtue of such dividend, distribution,
subdivision, combination or reclassification, and the Exercise Price shall
be appropriately adjusted. Such adjustment shall be made successively
whenever any event listed above shall occur.
(ii) ISSUANCE AT LESS THAN CURRENT MARKET PRICE. The issuance of Common
Stock (or other securities deliverable hereunder), rights, options
(excluding options issued in connection with an employee stock option or
similar plan) or warrants to all holders of Common Stock (or such other
securities deliverable hereunder) entitling them to subscribe for or
purchase Common Stock (or such other securities) at a price per share or
having a conversion price per share less than the Closing Price on such
record date (excluding rights or warrants that are not immediately
exercisable and for which provision is made for the Holder to receive
comparable rights or warrants), then the number of Warrant Shares to be
received hereunder after such record date shall be determined by multiplying
the number of shares receivable hereunder immediately prior to such record
date by a fraction, the denominator of which shall be the number of shares
of Common Stock (or such other securities deliverable hereunder) outstanding
on such record date plus the number of shares of Common Stock (or such other
securities) that the aggregate offering price of the total number of shares
so offered for subscription or purchase would purchase at such Closing
Price, and the numerator of which shall be the number of shares of Common
Stock (or such other securities) outstanding on such record date plus the
number of additional shares of Common Stock (or such other securities)
offered for subscription or purchase, and the Exercise Price shall be
appropriately adjusted. Shares of Common Stock owned by or held for the
account of the Company or any subsidiary of the Company on such record date
shall not be deemed outstanding for the purpose of any such computation.
Such adjustment shall become effective immediately after such record date.
Such adjustment shall be made
successively whenever any such event shall occur. If such rights or warrants
are not so issued, the number of Warrant Shares receivable hereunder shall
again be adjusted to be the number that would have been in effect had such
record date not been fixed. On the expiration of such rights or warrants the
number of Warrant Shares receivable hereunder shall be adjusted to be the
number that would have obtained had the adjustment made upon the issuance of
such rights or warrants been made upon the basis of the issuance of only the
number of shares of Common Stock (or such other securities deliverable
hereunder) actually issued upon the exercise of such rights or warrants. In
any case in which this subsection (ii) shall require that an adjustment in
the number of shares receivable hereunder or the Exercise Price be made
effective as of a record date for a specified event, the Company may elect
to defer until the occurrence of such event issuing to the Holder of any
Warrant exercised after such record date the number of Warrant Shares, if
any, issuable upon such exercise over and above the number of Warrant
Shares, if any, issuable upon such exercise on the basis of the Exercise
Price in effect prior to such adjustment; PROVIDED, HOWEVER, that the
Company shall deliver to such Holder a due bill or other appropriate
instrument evidencing such Holder's right to receive such additional Warrant
Shares upon the occurrence of the event requiring such adjustments.
(iii) DISTRIBUTION OF SUBSCRIPTION RIGHTS, WARRANTS, EVIDENCES OF
INDEBTEDNESS OR ASSETS. The making of a distribution to all holders of
Common Stock (or other securities deliverable hereunder) (including any such
distribution to be made in connection with a consolidation or merger in
which the Company is to be the continuing corporation) of (A) any shares of
capital stock of the Company (other than Common Stock), (B) subscription
rights or warrants (excluding those for which adjustment is provided in
subsection 8(a)(ii) above and excluding those that are not immediately
exercisable and for which provision is made for the Holder to receive
comparable subscription rights or warrants) or (C) evidences of its
indebtedness or assets (excluding (x) dividends paid in or distributions of
the Company's capital stock for which the number of Warrant Shares
receivable hereunder shall have been adjusted pursuant to paragraph 8(a)(i)
and (y) cash dividends or distributions payable out of earnings or surplus
not in excess of 10% of the average Closing Price for the thirty trading
days prior to the fifth day before the date of declaration) any of the
foregoing being hereinafter in this paragraph (iii) called the
"Securities"), then in each such case (unless the Company elects to reserve
shares or other units of such Securities for distribution to each Holder
upon exercise of the Warrant so that, in addition to the shares of the
Common Stock (or other securities deliverable hereunder) to which each
Holder is entitled, each Holder will receive upon such exercise the amount
and kind of such Securities which such Holder would have received if the
Company had, immediately prior to the record date for the distribution of
the Securities, exercised the Warrant) the number of Warrant Shares
receivable hereunder after such record date shall be determined by
multiplying the number of Warrant Shares receivable hereunder immediately
prior to such record date by a fraction, the denominator of which shall be
the Closing Price on the trading day immediately prior to the date the
Common Stock (or such other securities deliverable hereunder) trades without
the right to receive such Securities, less the fair market value (as
determined in the reasonable judgment of the Board of Directors of the
Company and described in a statement mailed by certified mail to the Holder)
of the portion of the assets or evidences of indebtedness so to be
distributed to a holder of one share of the Common Stock or of such
subscription rights or warrants applicable to one share of the Common Stock,
and the numerator of which shall be the Closing Price of the Common Stock on
such trading date; and the Exercise Price shall be appropriately adjusted.
Such adjustment shall become effective immediately after such record date
and shall be made successively whenever such a record date is fixed. If such
distribution is not so made, the number of Warrant Shares receivable
hereunder shall again be adjusted to be the number that was in effect
immediately prior to such record date. In any case in which this paragraph
(iii) shall require that an adjustment in the number of Warrant Shares
receivable hereunder or the Exercise Price be made effective as of a record
date for a specified event, the Company may
elect to defer until the occurrence of such event issuing to the Holder of
any Warrant exercised after such record date the number of Warrant Shares,
if any, issuable upon such exercise over and above the number of Warrant
Shares, if any, issuable upon such exercise on the basis of the Exercise
Price in effect prior to such adjustment; PROVIDED, HOWEVER, that the
Company shall deliver to such Holder a due bill or other appropriate
instrument evidencing such Holder's right to receive such additional Warrant
Shares upon the occurrence of the event requiring such adjustments.
(b) REORGANIZATION EVENT.
(i) In case of any Reorganization Event the Company shall, as a
condition precedent to the consummation of the transaction constituting, or
announced as, such Reorganization Event, cause effective provisions to be
made so that the Holder shall have the right immediately thereafter, by
exercising this Warrant, to receive the aggregate amount and kind of shares
of stock and other securities and property that were receivable upon such
Reorganization Event by a holder of the number of shares' of Common Stock
that would have been received immediately prior to such Reorganization Event
upon exercise of this Warrant. Any such provision shall include provision
for adjustments in respect of such shares of stock and other securities and
property that shall be as nearly equivalent as may be practicable to the
adjustments provided for in Section 8(a). The foregoing provisions of this
Section 8(b) shall similarly apply to successive Reorganization Events.
(ii) The Company shall, at least twenty days before earliest of (1) the
date on which a Reorganization Event occurs or (2) the date on which the
Company shall agree to effect a Reorganization Event (PROVIDED that if
approval of the shareholders of the Company is required in connection with
such Reorganization Event then on the date of such approval and PROVIDED
FURTHER that if such Reorganization Event was beyond the control of the
Company, and the Company did not have knowledge twenty days before the date
of such Reorganization Event, as soon as practicable thereafter), cause to
be mailed to the Holder a notice describing in reasonable detail such
Reorganization Event and informing the Holder of his or her rights pursuant
to Section 8(b)(i) above.
(c) FRACTIONAL SHARES. No fractional shares of Common Stock (or other
securities deliverable hereunder) or scrip shall be issued to any Holder in
connection with the exercise of this Warrant. Instead of any fractional share of
Common Stock (or other securities deliverable hereunder) that would otherwise be
issuable to such Holder, the Company shall pay to such Holder a cash adjustment
in respect of such fractional interest in an amount equal to such fractional
interest multiplied by the then current Closing Price per share of Common Stock
(or other securities deliverable hereunder).
(d) CARRYOVER. Notwithstanding any other provision of this Section 8, no
adjustment shall be made to the number of shares of Common Stock (or other
securities deliverable hereunder) to be delivered to each Holder (or to the
Exercise Price) if such adjustment would represent less than one percent of the
number of shares to be so delivered, but any such adjustment shall be carried
forward and shall be made at the time and together with the next subsequent
adjustment which, together with any adjustments so carried forward, shall amount
to one percent or more of the number of shares to be so delivered.
(e) NOTICES OF CERTAIN EVENTS. If at any time after the date hereof and
before the expiration of the Exercise Period:
(i) the Company authorizes the issuance to all holders of its Common
Stock of (A) rights or warrants to subscribe for or purchase shares of its
Common Stock or (B) any other subscription rights or warrants; or
(ii) the Company authorizes the distribution to all holders of its
Common Stock of evidences of its indebtedness or assets (other than cash
dividends or distributions excluded from the operation of paragraph
8(a)(iii); or
(iii) there shall be any capital reorganization of the Company or
reclassification of the Common Stock (other than a change in par value of
the Common Stock or an increase in the authorized capital stock of the
Company not involving the issuance of any shares thereof) or any
consolidation or merger to which the Company is a party (other than a
consolidation or merger with a subsidiary in which the Company is the
continuing corporation and that does not result in any reclassification or
change in the Common Stock outstanding) or a conveyance or transfer of all
or substantially all of the properties and assets of the Company;
(iv) there shall be any voluntary or involuntary dissolution,
liquidation or winding-up of the Company; or
(v) there shall be any other event that would result in an adjustment
pursuant to this Section 8 in the Exercise Price or the number of Warrant
Shares that may be purchased upon the exercise hereof;
the Company will cause to be mailed to the Holder, at least twenty days (or ten
days in any case specified in clauses (i) or (ii) above) before the applicable
record or effective date hereinafter specified, a notice stating (A) the date as
of which the holders of Common Stock of record entitled to receive any such
rights, warrants or distributions is to be determined, or (B) the date on which
any such reorganization, reclassification, consolidation, merger, conveyance,
transfer, dissolution, liquidation or winding-up is expected to become
effective, and the date as of which it is expected that holders of Common Stock
of record will be entitled to exchange their shares of Common Stock for
securities or other property, if any, deliverable upon such reorganization,
reclassification, consolidation, merger, conveyance, transfer, dissolution,
liquidation or winding-up.
(f) FAILURE TO GIVE NOTICE. The failure to give the notice required by
Section 8(e) hereof or any defect therein shall not affect the legality or
validity of any distribution right, warrant, consolidation, merger, conveyance,
transfer, dissolution, liquidation or winding-up or the vote upon any such
action.
9. OFFICERS' CERTIFICATE. Whenever the number of Warrant Shares that may be
purchased on exercise of this Warrant or the Exercise Price is adjusted as
required by the provisions of Section 8 hereof, the Company will forthwith file
in the custody of its Secretary or an Assistant Secretary at its principal
office and at the office of its agent an officers' certificate showing the
adjusted number of Warrant Shares that may be purchased at the Exercise Price on
exercise of this Warrant and the adjusted Exercise Price determined as herein
provided, setting forth in reasonable detail the facts requiring such adjustment
and the manner of computing such adjustment. Each such officers' certificate
shall be signed by the President, Chief Financial Officer or Treasurer of the
Company and by the Secretary or an Assistant Secretary of the Company. Each such
officers' certificate shall be made available at all reasonable times for
inspection by the Holder. The Company shall, forthwith after each such
adjustment, cause such certificate to be mailed to the Holder.
10. LISTING ON SECURITIES EXCHANGES. The Company will list on each national
securities exchange on which any Common Stock may at any time be listed or
quoted and have authorized for quotation on the National Market (if any Common
Stock is then authorized for quotation thereon) all shares of Common Stock from
time to time issuable upon exercise of all Warrants issued in connection with
the initial sale of the limited partnership interests in the Partnership,
subject to official notice of issuance (if required), and will maintain such
listing or quotation so long as any other shares of its Common Stock are so
listed or quoted. The Company shall so list or have authorized for quotation,
and shall maintain such listing or quotation of, any other shares of capital
stock of the Company
issuable upon the exercise of this Warrant if and so long as any shares of
capital stock of the same class are so listed or quoted. Any such listing or
quotation shall be at the Company's expense.
11. AVAILABILITY OF INFORMATION. The Company shall comply with all applicable
public information reporting requirements of the SEC and applicable state
securities laws (including those required to make available the benefits of Rule
144 under the Act) to which it may from time to time be subject. The Company
will also cooperate with each Holder of any Warrants and each holder of any
Warrant Shares in supplying such information concerning the Company as may be
necessary for such Holder or holder to complete and file any information
reporting forms currently or hereafter required by the SEC as a condition to the
availability of an exemption from the Act for the sale of any Warrants or
Warrant Shares.
12. WARRANT REGISTER. The Company will register this Warrant in the Warrant
Register in the name of the record holder to whom it has been distributed or
assigned in accordance with the terms hereof. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof (notwithstanding
any notation of ownership or other writing hereon made by anyone) for the
purpose of any exercise hereof or any distribution to the Holder and for all
other purposes, and the Company shall not be affected by any notice to the
contrary.
13. SUCCESSORS. All of the provisions of this Warrant by or for the benefit of
the Company or the Holder shall bind and inure to the benefit of their
respective successors and assigns.
14. HEADINGS. The headings of sections of this Warrant have been inserted for
convenience of reference only, are not to be considered a part hereof and shall
in no way modify or restrict any of the terms or provisions hereof.
15. AMENDMENTS. This Warrant may be amended by the affirmative vote of Holders
holding Warrants to purchase not less than two-thirds of the Warrant Shares
purchasable pursuant to all of the then outstanding Warrants; PROVIDED, that,
except as expressly provided herein, this Warrant may not be amended, without
the consent of the Holder, to change (i) any price at which this Warrant may be
exercised, (ii) the period during which this Warrant may be exercised, (iii) the
number or type of securities to be issued upon the exercise hereof or (iv) the
provision of this Section 15.
16. NOTICES. Unless otherwise provided in this Warrant, any notice or other
communication required or permitted to be made or given to any party hereto
pursuant to this Warrant shall be in writing and shall be deemed made or given
if delivered by hand, on the date of such delivery to such party or, if mailed,
on the fifth day after the date of mailing, if sent to such party by certified
or registered mail, postage prepaid, addressed to it (in the case of a Holder)
at its address in the Warrant Register or (in the case of the Company) at its
address set forth below, or to such other address as is designated by written
notice, similarly given to each other party hereto.
17. GOVERNING LAW. This Warrant shall be deemed to be a contract made under the
laws of the State of Delaware and for all purposes shall be construed in
accordance with the laws of said State as applied to contracts made and to be
performed in Delaware between Delaware residents.
18. SIGNATURES. This Warrant and any Warrant issued pursuant to the terms
hereof shall be manually signed, or shall bear the facsimile signature of the
President or a Vice President of the Company which shall have the same effect as
if such Warrant were manually signed.
IN WITNESS WHEREOF, the Company has duly caused this Warrant to be signed
and attested by its duly authorized officers as of October 21, 1997.
REPLIGEN CORPORATION
By:
------------------------------------------
Xxxxxx X. Xxxxxxx
President and CEO
Address:
000 Xxxxxx Xxxxxx
Xxxxxxx, XX 00000
Attention: Secretary
PURCHASE FORM
The undersigned, _____________________ hereby irrevocably elects to exercise
the within Warrant to purchase ______shares of Common Stock and hereby makes
payment of $_________ in payment of the exercise price thereof.
Date: ______________, 19__ ___________________________
[Signed]
___________________________
[Street Address]
___________________________
[City and State]
WARRANT ASSIGNMENT FORM
FOR VALUE RECEIVED, the undersigned, _____________________, ("ASSIGNOR"),
hereby sells, assigns and transfers unto
Name: _______________________ ("Assignee")
(Please type or print in block letters.)
Address: _______________________________________
_______________________________________
Social Security or Taxpayer I.D. No.: __________
Assignor's right to purchase up to ______ shares of Common Stock represented
by this Warrant and does hereby irrevocably constitute and appoint the Company
and any of its officers, secretary, or assistant secretaries, as
attorneys-in-fact to transfer the same on the books of the Company, with full
power of substitution in the premises.
Date: ___________, 199__ _______________________
[Signed]
